Lv1
50 积分 2025-11-25 加入
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown
4个月前
已完结
Are GLP-1 receptor agonists a ‘magic bullet’ for cancer?
5个月前
已完结
Mechanisms, challenges and opportunities for FLASH radiotherapy in cancer
5个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
7个月前
已完结
Polo-like kinases as immune modulators: a new frontier in cancer immunotherapy
7个月前
已完结
IL-23 in inflammatory bowel diseases and colon cancer
7个月前
已完结
皖公网安备34019202002308
